Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1B1 | Q16678 | 15/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6889202 | 0.88 | ALDH1A1 (0.49) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL21069711 | 0.81 | HPGD (0.46) | ALDH1A1MEN1LMNAMAPTKMT2A | |
| SCHEMBL31419834 | 0.77 | CYP1A2 (0.53) | ALDH1A1KDM4EMEN1LMNAMAPT | |
| SCHEMBL21988116 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL6885843 | 0.74 | CYP1B1 (0.69) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL23295234 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL28412907 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL21988126 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL23295238 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 | |
| SCHEMBL31146710 | 0.74 | POLB (0.70) | CYP1B1ALDH1A1POLBKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6682938-B1 | USING COMPOUND HAVING SUBSTRATE-RECOGNITION COMPONENT, FLUORESCENCE ?SWITCH? MEDIATED BY SUBSTRATE RECOGNITION EVENT, AND FLUOROPHORE IN MOLECULE IN IMPLANTABLE SYSTEMS FOR CONTINUOUS TRANSDERMAL MONITORING OF BLOOD GLUCOSE LEVELS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-01-27 | — | — | US | disclosed |
| US-6673625-B2 | NAPTHALIMIDE BORONATE DERIVATIVES AND SUBSTITUTED CHLOROBENZOPHENOXAZINONE BORONATE DERIVATIVES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-01-06 | — | — | US | disclosed |
| EP-1214596-A1 | GLUCOSE SENSING MOLECULES HAVING SELECTED FLUORESCENT PROPERTIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-06-19 | — | — | EP | disclosed |
| US-20020010279-A1 | Saccharide sensing molecules having enhanced fluorescent properties | LAWRENCE LIVERMORE NATIONAL SECURITY LLC | 2002-01-24 | — | — | US | disclosed |
| WO-2001020334-A1 | GLUCOSE SENSING MOLECULES HAVING SELECTED FLUORESCENT PROPERTIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010279-A1 | Saccharide sensing molecules having enhanced fluorescent properties | SLC2A1, SLC2A9, SLC2A2 | CYP1B1 756/4885ALDH1A1 261/4885POLB 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.